Go Pro

CRISPR Therapeutics (CRSP) Institutional Ownership

CRISPR Therapeutics logo
$47.99 0.00 (0.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$48.22 +0.23 (+0.48%)
As of 07/31/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for CRISPR Therapeutics (NASDAQ:CRSP)

Current
Institutional Ownership
Percentage
69.20%
Number of
Institutional Buyers
(last 12 months)
283
Total
Institutional Inflows
(last 12 months)
$839.40M
Number of
Institutional Sellers
(last 12 months)
142
Total
Institutional Outflows
(last 12 months)
$386.69M
Get CRSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CRSP Institutional Buying and Selling by Quarter

CRISPR Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/10/2026 Handelsbanken Fonder AB35,000$1.91M0.0%+30.1%0.036%
7/9/2026 Hennion & Walsh Asset Management Inc.30,485$1.66M0.0%+16.9%0.032%
7/9/2026 Valeo Financial Advisors LLC3,689$201K0.0%N/A0.004%
7/8/2026 Thurston Springer Miller Herd & Titak Inc.1,637$89K0.0%+184.2%0.002%
7/8/2026 Brave Asset Management Inc.11,234$613K0.1%-67.7%0.012%
7/7/2026 180 Wealth Advisors LLC7,257$396K0.0%-2.3%0.008%
7/7/2026 Quad Cities Investment Group LLC4,164$227K0.1%N/A0.004%
7/2/2026 Versant Capital Management Inc465$25K0.0%+175.1%0.000%
5/20/2026Norris Financial Group LLC7,257$345K0.1%N/A0.008%
5/19/2026Western Wealth Management LLC1,967$94K0.0%N/A0.002%
5/19/2026Bank of America Corp DE983,072$46.77M0.0%-10.4%1.019%
5/19/2026Janus Henderson Group PLC40,274$1.92M0.0%+15.8%0.042%
5/18/2026Sunbelt Securities Inc.7,843$373K0.0%+4.5%0.008%
5/18/2026Amundi8,262$393K0.0%N/A0.009%
5/18/2026 EverSource Wealth Advisors LLC89,683$4.27M0.1%+56.1%0.093%
5/18/2026California State Teachers Retirement System101,232$4.82M0.0%+29.6%0.105%
5/18/2026Readystate Asset Management LP20,933$996K0.0%N/A0.022%
5/18/2026Royal Bank of Canada163,720$7.79M0.0%-1.1%0.170%
5/16/2026The Manufacturers Life Insurance Company 43,777$2.08M0.0%+5.4%0.045%
5/16/2026Quantinno Capital Management LP47,989$2.28M0.0%+613.5%0.050%
5/16/2026Clough Capital Partners L P24,685$1.17M0.1%+7.3%0.026%
5/16/2026SummitTX Capital L.P.4,448$212K0.0%N/A0.005%
5/16/2026Lazard Asset Management LLC47,065$2.24M0.0%-6.3%0.049%
5/15/2026Quadcap Wealth Management LLC4,840$230K0.0%+25.4%0.005%
5/15/2026Waverly Advisors LLC18,124$862K0.0%+24.9%0.019%
5/15/2026Affinity Asset Advisors LLC150,000$7.14M0.4%N/A0.156%
5/15/2026Entropy Technologies LP14,067$669K0.0%N/A0.015%
5/14/2026Inceptionr LLC6,577$313K0.1%N/A0.007%
5/14/2026Sei Investments Co.15,825$753K0.0%+25.0%0.016%
5/14/2026Monashee Investment Management LLC50,000$2.38M1.3%N/A0.052%
5/13/2026Cetera Investment Advisers59,245$2.82M0.0%-7.3%0.061%
5/12/2026Himension Capital Singapore PTE. LTD.92,481$4.40M0.3%+9.6%0.096%
5/8/2026PNC Financial Services Group Inc.8,202$390K0.0%+6.3%0.009%
5/8/2026Cassaday & Co Wealth Management LLC2,260$108K0.0%N/A0.002%
5/8/2026Amova Asset Management Americas Inc.1,853,875$88.19M1.2%-5.3%1.922%
5/7/2026Hollencrest Capital Management1,312$62K0.0%+249.9%0.001%
5/7/2026Dimensional Fund Advisors LP494,218$23.49M0.0%-45.5%0.512%
5/7/2026KBC Group NV116,847$5.56M0.0%+3,999.9%0.121%
5/7/2026Swiss National Bank169,700$8.07M0.0%+5.1%0.176%
5/6/2026Allspring Global Investments Holdings LLC5,932$290K0.0%+11.4%0.006%
Porter flew 3,300 miles to investigate this system (Ad)

Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel

Watch the full investigation and decide for yourself
5/6/2026 Independent Financial Group LLC6,136$292K0.0%N/A0.006%
5/5/2026Wealthfront Advisers LLC8,545$406K0.0%-6.6%0.009%
5/5/2026 D.A. Davidson & CO.6,324$301K0.0%+5.9%0.007%
5/5/2026Bank of New York Mellon Corp311,383$14.81M0.0%+0.1%0.323%
5/5/2026Sanctuary Advisors LLC9,937$473K0.0%-11.1%0.010%
5/5/2026 Nwam LLC9,173$436K0.0%-85.2%0.010%
5/4/2026 Canal Insurance CO35,100$1.67M0.4%N/A0.036%
5/2/2026 CAP Partners LLC4,301$205K0.1%N/A0.004%
5/2/2026Gables Capital Management Inc.4,000$190K0.1%N/A0.004%
5/2/2026SFE Investment Counsel14,120$672K0.1%+12.1%0.015%
5/1/2026Farrow Financial Inc.16,979$808K0.5%+5.3%0.018%
4/30/2026 Mason & Associates Inc7,051$313K0.1%+19.0%0.007%
4/30/2026 Kestra Advisory Services LLC21,052$1.00M0.0%+2.0%0.022%
4/30/2026Money Concepts Capital Corp4,738$225K0.0%N/A0.005%
4/30/2026 Sumitomo Mitsui Trust Group Inc.1,853,875$88.19M0.1%-5.3%1.922%
4/29/2026 Axxcess Wealth Management LLC14,074$669K0.0%+8.1%0.015%
4/29/2026Saxon Interests Inc.14,596$694K0.2%N/A0.015%
4/27/2026Moran Wealth Management LLC25,302$1.20M0.0%+52.6%0.026%
4/27/2026 Private Advisor Group LLC106,662$5.07M0.0%-0.6%0.111%
4/25/2026 Strs Ohio17,923$853K0.0%-23.8%0.019%
4/23/2026 Formidable Asset Management LLC7,298$383K0.1%+100.1%0.008%
4/22/2026 Patriot Financial Group Insurance Agency LLC47,550$2.26M0.1%+104.7%0.050%
4/22/2026 Pictet Asset Management Holding SA154,007$6.87M0.0%-8.0%0.160%
4/22/2026 Sterling Capital Management LLC3,037$144K0.0%-39.9%0.003%
4/21/2026 Generali Investments Towarzystwo Funduszy Inwestycyjnych15,000$714K0.4%-11.8%0.016%
4/20/2026 Kestra Private Wealth Services LLC11,064$526K0.0%-3.4%0.012%
4/20/2026Banque Cantonale Vaudoise17,463$831K0.0%-1.3%0.018%
4/17/2026 AdvisorNet Financial Inc8,003$381K0.0%+16.1%0.008%
4/16/2026SG Americas Securities LLC3,737$178K0.0%-73.0%0.004%
3/17/2026Rockefeller Capital Management L.P.112,667$5.91M0.0%-24.1%0.117%
3/13/2026Fund Advisors of America Inc FL7,583$398K0.4%N/A0.008%
3/9/2026Corient Private Wealth LLC4,566$239K0.0%-43.7%0.005%
2/23/2026Virtu Financial LLC16,444$862K0.0%N/A0.017%
2/19/2026Mcguire Capital Advisors Inc.468$25K0.0%N/A0.000%
2/19/2026T. Rowe Price Investment Management Inc.3,226,595$169.20M0.1%-1.7%3.361%
2/19/2026Invesco Ltd.60,796$3.19M0.0%-6.9%0.063%
2/19/2026 Axxcess Wealth Management LLC13,022$683K0.0%+6.2%0.014%
2/19/2026Corient Private Wealth LLC8,566$449K0.0%+5.7%0.009%
2/19/2026Jacobs Equity LLC12,090$634K0.6%N/A0.013%
2/18/2026Alpine Woods Capital Investors LLC8,085$424K0.1%-2.3%0.008%
2/18/2026Mackenzie Financial Corp5,187$275K0.0%-4.3%0.005%
2/18/2026NewEdge Advisors LLC3,558$187K0.0%-66.2%0.004%
2/18/2026Empowered Funds LLC3,148$165K0.0%N/A0.003%
2/18/2026Virtus Investment Advisers LLC12,056$632K0.2%+12.0%0.013%
2/18/2026Susquehanna Portfolio Strategies LLC31,015$1.63M0.0%-17.3%0.033%
2/18/2026Twinbeech Capital LP4,072$214K0.0%N/A0.004%
2/18/2026Millennium Management LLC30,492$1.60M0.0%-64.7%0.032%
2/18/2026Man Group plc8,589$450K0.0%N/A0.009%
2/18/2026Engineers Gate Manager LP25,950$1.36M0.0%N/A0.027%
2/18/2026 Align Financial LLC13,110$687K0.0%N/A0.014%
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
2/17/2026Guggenheim Capital LLC57,021$2.99M0.0%-0.8%0.059%
2/17/2026AQR Capital Management LLC20,746$1.09M0.0%-26.9%0.022%
2/17/2026 Abel Hall LLC5,100$267K0.1%N/A0.005%
2/17/2026EFG International AG1,377$72K0.0%N/A0.001%
2/17/2026Lazard Asset Management LLC50,246$2.64M0.0%-13.9%0.052%
2/17/2026Hilltop Holdings Inc.10,322$541K0.0%N/A0.011%
2/17/2026Equitable Holdings Inc.5,764$302K0.0%-4.3%0.006%
2/17/2026 Kovack Advisors Inc.4,576$240K0.0%N/A0.005%
2/17/2026Orbis Allan Gray Ltd5,950,145$312.03M1.3%+19.4%6.199%
2/17/2026Jump Financial LLC6,478$340K0.0%N/A0.007%


CRSP Institutional Ownership - Frequently Asked Questions

During the previous two years, 430 institutional investors and hedge funds held shares of CRISPR Therapeutics. The most heavily invested institutionals were ARK Investment Management LLC ($551.78M), Orbis Allan Gray Ltd ($312.03M), Capital International Investors ($309.02M), State Street Corp ($196.83M), T. Rowe Price Investment Management Inc. ($169.20M), GSK plc ($168.89M), and UBS Group AG ($132.37M).Learn more on CRISPR Therapeutics' institutional investors.

69.20% of CRISPR Therapeutics' stock is owned by institutional investors. Learn more on CRSP's institutional investor holdings.

Of the 383 institutional investors that purchased CRISPR Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: ARK Investment Management LLC ($3.42M), GSK plc ($3.22M), Orbis Allan Gray Ltd ($2.26M), State Street Corp ($1.46M), UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($1.43M), Norges Bank ($1.34M), and Baker BROS. Advisors LP ($1.21M).

Institutional investors have bought a total of 15,819,769 shares in the last 24 months. This purchase volume represents approximately $839.40M in transactions.

Of the 142 institutional investors that sold CRISPR Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: T. Rowe Price Investment Management Inc. ($1.49M), Sumitomo Mitsui Trust Group Inc. ($560.96K), Amova Asset Management Americas Inc. ($560.40K), Two Sigma Investments LP ($501.28K), Dimensional Fund Advisors LP ($453.57K), ARK Investment Management LLC ($395.62K), and Versant Venture Management LLC ($349.73K).

Institutional investors have sold a total of 6,877,940 shares in the last 24 months. This volume of shares sold represents approximately $386.69M in transactions.



This page (NASDAQ:CRSP) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners